drugset / Trial / NCT01014871

Comparison of Two Botulinum Toxins Type A on Forehead Wrinkles

NCT01014871 ↗

Phase 2 Completed 30 enrolled Galderma R&D
RandomizedSingle-groupSingle-blindTreatment

Summary

Single-centre, controlled, randomized, evaluator-blinded, bilateral (split-face) comparison study in subjects with moderate to severe forehead wrinkles. One botulinum toxin type A will be injected in one side of the forehead and the other one will be injected in the other side of the forehead at baseline. Allocation of each BoNT-A to each side of the forehead will be randomized.

Timeline

Start
2009-07
Primary completion
2010-04
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Azzalure Protein / enzyme biologic — Other
Subject Vistabel Unknown — Other

Indications

No indication recorded.